Health
Study shows vaccine’s potential to stop viral spread – The Australian Financial Review
The news is potentially good for Australia as the Oxford-AstraZeneca vaccine is being manufactured onshore by CSL.
The study design focused on the interval between the two jabs and how this affected the level of protection against becoming ill with COVID-19.
But it covered transmission too, as the Oxford University newsletter explains:
The authors also report further on the potential for the vaccine to reduce transmission of the virus, based on swabs obtained from volunteers in the UK arms of the trial with a 67 per cent reduction after the first dose of the vaccine.
But they say the data is preliminary and…
-
Noosa News18 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
Business18 hours agoHow did the market react to this dividend stock’s earnings results?